Multinational Device Makers To Lower India Prices For Resistant-TB Tests
This article was originally published in PharmAsia News
Executive Summary
Several multinational makers of medical devices have agreed to join with private India laboratories to provide low-cost diagnostics for detecting the presence of a tuberculosis strain resistant to the dozen standard treatments.